Literature DB >> 24900503

Cracking the code: the promise of epigenetics.

Dashyant Dhanak1.   

Abstract

Year:  2012        PMID： 24900503      PMCID： PMC4025814          DOI： 10.1021/ml300141h

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  4 in total

Review 1.  Epigenetic protein families: a new frontier for drug discovery.

Authors:  Cheryl H Arrowsmith; Chas Bountra; Paul V Fish; Kevin Lee; Matthieu Schapira
Journal:  Nat Rev Drug Discov       Date:  2012-04-13       Impact factor: 84.694

Review 2.  The emerging therapeutic potential of histone methyltransferase and demethylase inhibitors.

Authors:  Astrid Spannhoff; Alexander-Thomas Hauser; Ralf Heinke; Wolfgang Sippl; Manfred Jung
Journal:  ChemMedChem       Date:  2009-10       Impact factor: 3.466

Review 3.  Current chemical biology approaches to interrogate protein methyltransferases.

Authors:  Minkui Luo
Journal:  ACS Chem Biol       Date:  2012-02-01       Impact factor: 5.100

Review 4.  Epigenetic modifications as therapeutic targets.

Authors:  Theresa K Kelly; Daniel D De Carvalho; Peter A Jones
Journal:  Nat Biotechnol       Date:  2010-10       Impact factor: 54.908
  4 in total
  4 in total

Review 1.  Modulation of epigenetic targets for anticancer therapy: clinicopathological relevance, structural data and drug discovery perspectives.

Authors:  Federico Andreoli; Arménio Jorge Moura Barbosa; Marco Daniele Parenti; Alberto Del Rio
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.310

Review 2.  Computer-aided Molecular Design of Compounds Targeting Histone Modifying Enzymes.

Authors:  Federico Andreoli; Alberto Del Rio
Journal:  Comput Struct Biotechnol J       Date:  2015-05-07       Impact factor: 7.271

3.  Optimization of 3,5-dimethylisoxazole derivatives as potent bromodomain ligands.

Authors:  David S Hewings; Oleg Fedorov; Panagis Filippakopoulos; Sarah Martin; Sarah Picaud; Anthony Tumber; Christopher Wells; Monica M Olcina; Katherine Freeman; Andrew Gill; Alison J Ritchie; David W Sheppard; Angela J Russell; Ester M Hammond; Stefan Knapp; Paul E Brennan; Stuart J Conway
Journal:  J Med Chem       Date:  2013-04-05       Impact factor: 7.446

4.  Synthesis and Structure-Activity Relationships of Aristoyagonine Derivatives as Brd4 Bromodomain Inhibitors with X-ray Co-Crystal Research.

Authors:  Minjin Yoo; Tae Hyun Park; Miyoun Yoo; Yeongrin Kim; Joo-Youn Lee; Kyu Myung Lee; Seong Eon Ryu; Byung Il Lee; Kwan-Young Jung; Chi Hoon Park
Journal:  Molecules       Date:  2021-03-17       Impact factor: 4.411
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.